ShardaCare Healthcity in Collaboration with GIFT Hosts Thalassaemia Awareness Program with a Free HLA Testing Camp: Giving Children a Chance at Cure

▴ Free HLA Testing Camp
ShardaCare Healthcity, a leading super-speciality hospital in Greater Noida, renowned for its advanced clinical capabilities and patient-centric approach, is organising a Bone Marrow Transplant (BMT) Awareness Program and Free Human Leukocyte Antigen (HLA) Testing Camp in collaboration with the Globally Integrated Foundation for Thalassaemia (GIFT).

Greater Noida, January 13th 2026: ShardaCare Healthcity, a leading super-speciality hospital in Greater Noida, renowned for its advanced clinical capabilities and patient-centric approach, is organising a Bone Marrow Transplant (BMT) Awareness Program and Free Human Leukocyte Antigen (HLA) Testing Camp in collaboration with the Globally Integrated Foundation for Thalassaemia (GIFT). The camp will be led by Dr. Pawan Kumar Singh, Senior Specialist in Blood Disorders and Bone Marrow Transplantation. The awareness session will educate families about thalassaemia, available treatment options, such as bone marrow transplant, and the importance of early intervention. The free HLA testing camp will aim to identify suitable sibling donors - an essential factor for successful transplantation.

Thalassaemia is a serious paediatric blood disorder with far-reaching health implications. As a genetic condition, it often requires affected children to undergo lifelong, regular blood transfusions, placing a significant physical, emotional, and financial burden on families. India carries a substantial share of the global thalassaemia burden, with an estimated 10,000–15,000 children born with thalassaemia major every year. Despite this, limited awareness, delayed diagnosis, and restricted access to advanced treatments - such as Bone Marrow Transplant (BMT)- continue to pose major challenges. Encouragingly, medical advancements like BMT offer a curative option, holding the potential to free children from lifelong transfusions and dramatically improve their quality of life.

Dr Kousar Shah, Group CEO, Shardacare Healthcity, said,”At ShardaCare Healthcity, our mission has always been to bridge the gap between advanced Healthcare and the people who need it most. Thalassaemia is a daunting challenge for any family, but with the right clinical expertise and timely intervention, it is a challenge that we can overcome. By hosting this HLA testing camp, we are not just providing a diagnostic service; we are providing a pathway to cure. We remain steadfast in our commitment to making high-end super-speciality treatments like Bone Marrow Transplants accessible and affordable, ensuring that every child has the opportunity to lead a life free from the burden of chronic illness.”

Dr. Pawan Kumar Singh, Senior Specialist in Blood Disorders and Bone Marrow Transplantation, said, “Blood disorders such as thalassaemia is not just a complex medical condition - they place an immense emotional and financial strain on families. While Bone Marrow Transplant offers a life-changing and potentially curative solution, many children continue to remain undiagnosed or untreated due to limited awareness and access to resources. Through timely diagnosis, increased awareness, and improved access to care, we can give these children a real chance at a healthier and brighter future”.

Adding to this, Madan Chawla, Founder, GIFT, said, “The very first and most critical step towards a bone marrow transplant is HLA testing. Unfortunately, this test is expensive and out of reach for many families. Without HLA testing, a transplant is simply not possible. Through this camp, our aim is to remove this barrier and offer free HLA testing to economically weaker families, enabling them to take the first step towards a cure.”

This initiative marks a significant step towards reducing the treatment gap for thalassaemia patients and reinforcing the commitment of GIFT and Sharda Care Health City towards inclusive and compassionate healthcare.

The camp is on Saturday, 17 January 2026, at 10:00 a.m., at Shardacare Healthcity, Greater Noida. Registration is mandatory for thalassaemic children and their families to participate in the camp. Interested families can register and seek further information by contacting Madan Chawla, Founder, GIFT, via WhatsApp at +91 9811089975.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Healthcare Trends in 2026: What India's Doctors, Hospitals, and Patients Need to KnowJuly 18, 2026
Monsoon Health Problems in India: Understanding the Risks, Symptoms, and PreventionJuly 18, 2026
Fortis Escorts Faridabad Launches Faridabad’s First Comprehensive Lung Failure Clinic for Advanced Respiratory and Transplant CareJuly 17, 2026
What Seemed Like Persistent Gas Turned Out To Be A 30-cm Rare Cancer Occupying Most Of Her AbdomenJuly 17, 2026
Kidney Stone Prevention Initiative Unites More Than 8,200 Doctors Across India, Earns Asia Book of Records RecognitionJuly 17, 2026
Moscow radiologists introduce AI tool for hip dysplasia diagnosisJuly 17, 2026
Sharrp Ventures leads 100 CR investment in Naturis Cosmetics’ first institutional funding roundJuly 17, 2026
Eugenix Challenges Hair Loss Stigma With Nationwide 'I Chose Transformation' Campaign Featuring Boney KapoorJuly 17, 2026
How Artificial Intelligence is Reshaping Preventive Healthcare Through Earlier Detection and Smarter Clinical InsightsJuly 17, 2026
Five Common Myths About Children's Urinary Problems That Parents Should Stop BelievingJuly 17, 2026
Robotics in Surgery: How Robot-Assisted Procedures Are Transforming Healthcare in IndiaJuly 17, 2026
Wearable Health Devices: How Smart Technology Is Changing Healthcare in IndiaJuly 17, 2026
Sankara Eye Hospitals Successfully Hosts 20th Annual VISION 2020 India Conference, Celebrating 50 Years of the Sankara MovementJuly 16, 2026
Manipal Hospital Bhubaneswar Successfully Treats Rare Brain Injury Caused by Post-Traumatic Workplace AccidentJuly 16, 2026
Immuneel Therapeutics and Tata Memorial Centre Sign Strategic MoU to Advance Cell and Gene Therapy Research in India July 16, 2026
Breast Cancer Early Warning Signs: What Every Woman in India Needs to KnowJuly 16, 2026
HbA1c Test Explained: What It Measures, Normal Range, and Why It Matters for IndiansJuly 16, 2026
Not Just Weight Loss: How Bariatric Surgery Improves Diabetes, PCOS, and Thyroid-Related Health ChallengesJuly 15, 2026
Leiutis Pharmaceuticals announces CDSCO approval for Global-First Synthetic CBD Therapy for Mild to Moderate Anxiety DisordersJuly 15, 2026
Dr Agarwals Institute of Optometry and SASTRA University Jointly Launch Optometry ProgrammeJuly 15, 2026